Data management

Formedix launches cloud-based clinical metadata repository

28-Jun-2021 By Jenni Spinner

The company’s ryze technology combines a clinical MDR and study automation platform, designed to accelerate and optimize design and execution of trials.

Cancer patient survey shows COVID's impact on care decisions

25-Jun-2021 By Jenni Spinner

The survey, conducted by Ai-powered study matching company TrialJectory, indicates more patients than ever are interested in clinical trial participation post-pandemic.

Sanofi, CytoReason join forces on AI-based asthma research

24-Jun-2021 By Jenni Spinner

The project will use the artificial intelligence specialist’s cell-centered models and deconvolutions to gain insights for each individual asthma endotype.

Tech Innovations: June 2021

23-Jun-2021 By Jenni Spinner

This month’s roundup of new equipment, materials, tech partnerships and other news includes items from Ajinomoto, Evonik, Quanticate, Pharmasol, and more.

COTA, University of Chicago to study racial disparities in cancer treatment

23-Jun-2021 By Jenni Spinner

The research collaboration is aimed at studying disparities in care with a focus on multiple myeloma, a cancer disproportionately affecting Black patients.

Gilead shares positive findings for potential COVID-19 treatment

22-Jun-2021 By Jenni Spinner

The pharma firm reports its Veklury (remdesivir) led to a reduction in mortality rate among hospitalized patients in three analyses of real-world data.

Mobile patient engagement solution lands industry award

18-Jun-2021 By Jenni Spinner

United BioSource received the 2021 Healthiverse Heroes Award for Life Sciences in recognition of its automated clinical trial patient outreach technology.

FDA issues guidance for measuring PROs in oncology studies

17-Jun-2021 By Jenni Spinner

The US federal agency has released a document designed to help clinical trial teams obtain effective, efficient data from patients in their cancer research.

Partnership delivers research, care to diverse communities

17-Jun-2021 By Jenni Spinner

Elligo Health Research is joining forces with Laguna Clinical Research Associates to expand access to clinical care to a broader range of patient populations.

Jazz Pharma collaborates wiith groups on digital cancer community

17-Jun-2021 By Jenni Spinner

The pharma firm is collaborating with oncology organizations on Nothing Small About it, a resource for small-cell lung cancer patients and their loved ones.

DIA 2021 Annual Meeting

‘Magic happens’ when pharma pros meet to share ideas: DIA

16-Jun-2021 By Jenni Spinner

A leader with the association discusses the value in attending events like the DIA 2021 Annual Meeting gather to tackle COVID-19 and other challenges.

DIA 2021 Annual Meeting

Study solutions take center stage at DIA 2021 Annual Meeting

16-Jun-2021 By Jenni Spinner

These organizations hope to connect with attendees at the event, sharing clinical research ideas and innovations in sessions and the virtual exhibit hall.

DIA 2021 Annual Meeting

DIA 2021 set to shed some light on decentralized trials process, accelerated approval pathways

16-Jun-2021 By Jane Byrne

Decentralized trials and remote monitoring, long discussed, but never really taking off until COVID-19 disrupted studies last year, will be under the spotlight at the DIA 2021 Annual Meeting at the end of this month.

DIA 2021 Annual Meeting

Skills of the future – and the future of work

15-Jun-2021 By Rachel Arthur

Whether working in the pharmaceutical industry or in academia or government, the skills required to achieve, maintain and grow a career are vastly different today than they were 30 years ago. A session at DIA 2021 will put the spotlight on the skills...

Australia, NZ appealing to clinical researchers: Greenphire

14-Jun-2021 By Jenni Spinner

Thanks in part to swift COVID-19 response and relatively low infection rates, more sites and sponsors are looking at the region to locate their studies.

BioCelerate, FDA forge nonclinical data partnership

10-Jun-2021 By Jenni Spinner

The two organizations have formed a public-private partnership aimed at improving nonclinical research through better practices and standardization.

Michael J. Fox Foundation shares Parkinson’s genetic data

08-Jun-2021 By Jenni Spinner

In partnership with 23andMe, the group has released a wealth of new de-identified data from the largest-ever Parkinson’s cohort, to aid future research.

Phesi COVID-19 study indicates obesity a major complicating factor

07-Jun-2021 By Jenni Spinner

The virtual clinical development firm’s analysis of patient profiles reflects obesity is the most significant indicator for severity in those under 40.

Group unites industry leaders to streamline digital clinical solutions

04-Jun-2021 By Jenni Spinner

The Digital Health Measurement Collaborative Community is bringing together stakeholders to improve approaches and technologies in research and healthcare.

KU Cancer Center forges SIP partnership with Complion

03-Jun-2021 By Jenni Spinner

The University of Kansas Cancer Center has joined with trial tech provider Complion to develop a shared investigator platform for use in a range of studies.

AstraZeneca taps Reify Health platform to boost breast cancer trials

03-Jun-2021 By Jenni Spinner

The pharma firm plans to use the StudyTeam platform to accelerate development, ease site burdens and improve patient matching for breast cancer studies.

People on the Move: June 2021

02-Jun-2021 By Jenni Spinner

This month’s roundup of hires, acquisitions, anniversaries, and other announcements includes news from Premier Research, Cytel, ACG, and other companies.

Greenphire acquired by tech-focused private equity investment firm

01-Jun-2021 By Jenni Spinner

The trial services firm has entered an acquisition agreement with Thoma Bravo, a private equity company centered on software and technology services.

BBK Worldwide launches patient-centric trial resource

25-May-2021 By Jenni Spinner

With the Engagement Solution Center, the patient-recruitment services specialist is aiming to improve the patient-centricity and inclusivity of studies.

Sanofi: pervasive patient centricity is a must for study success

24-May-2021 By Jenni Spinner

According to a leader from the pharma firm, considering a patient’s needs and seeing them as a whole person is vital to successful studies and drug design.

Digital experience impacts clinical trial success: Medallia

21-May-2021 By Jenni Spinner

A representative from the digital experience management firm discusses how improving the quality of tech interactions with patients can elevate results.

Reify, SubjectWell partner to elevate trial recruitment

21-May-2021 By Jenni Spinner

The two tech-focused firms are joining forces to work on technology solutions aimed at improving patient recruitment and enrollment for various studies.

Innovation drives improvement in decentralized trials: ObvioHealth

20-May-2021 By Jenni Spinner

An executive from the virtual research organization discusses the importance of advancing studies through innovation and a patient-centric approach.

Starting studies right can ensure a stronger finish: Oracle

20-May-2021 By Jenni Spinner

A leader from the clinical trial technology firm suggests ways to design research from the start to help accelerate studies and avoid stumbling blocks.

Drug development advancements call for skilled workforce

20-May-2021 By Jenni Spinner

According to a leader from Saama Technologies, keeping competitive in the face of technology evolution requires staff that can keep up with the changes.

Tech Innovations: May 2021

19-May-2021 By Jenni Spinner

This month’s roundup of new equipment, technology partnerships, and other news includes items from Ajinomoto, Elligo, Syneos, ACD/Labs and other companies.

Artificial intelligence can elevate pharma manufacturing

18-May-2021 By Jenni Spinner

According to a leader from industrial AI specialist AspenTech, AI can help avoid costly maintenance interruptions by predicting when upkeep is needed.

Drug developer uses RWE to research psychedelic therapies

13-May-2021 By Jenni Spinner

The UK-based development and research firm hopes to accelerate patient access to psychedelic therapies for treatment of various mental health conditions.

Getting cancer trials back on track after COVID-19

11-May-2021 By Jenni Spinner

A leader from oncology trial insights and analysis specialist Inteliquet discusses how cancer studies can recover after the impact of the global pandemic.

Veeva, Parexel forge partnership to accelerate trials

10-May-2021 By Jenni Spinner

The trial technology provider and contract research organization will collaborate on tech and process solutions designed to accelerate clinical studies.

THE FUTURE OF CLINICAL TRIALS

Industry veteran suggests solutions to strengthen clinical care

10-May-2021 By Jenni Spinner

In this second part of a series on the state of clinical research, a leader from Javara lays out ideas to bring clinical research and care closer together.

Science 37 to merge with LifeScience Acquisition II

07-May-2021 By Jenni Spinner

The newly formed company (valued at $1.05b USD) will center on funding the firm’s decentralized trial technology platform and exploring new opportunities,

Florence lands $80m investment to grow remote trial tech

06-May-2021 By Jenni Spinner

In the face of increasing demand for decentralized clinical trials and remote technology, the company has received funding to enable its further expansion.

Sponsors must rethink ‘primitive’ clinical trial approaches: Phesi

04-May-2021 By Jenni Spinner

A leader from the clinical development services provider recommends using industry modal values to avoid protocol amendments, enrollment problems and more.

Tapping into ePRO yields cost, accuracy benefits: Phastar

29-Apr-2021 By Jenni Spinner

A leader from the CRO talks about increased use of electronic patient-reported outcomes in research, challenges of adoption, and how ePRO benefits trials.

ERT, Bioclinica merger unites clinical trial tech teams

28-Apr-2021 By Jenni Spinner

The combination of companies brings together ERT’s clinical endpoint data capabilities and Bioclinica’s imaging, eClinical and drug-safety solutions.

Thermo Fisher: $17.4b PPD buy ‘natural extension’ for pharma

26-Apr-2021 By Jenni Spinner

The chairman, president and CEO of Thermo Fisher says the acquisition stands to benefit clinical trial and drug development clients in a long list of ways.

CRAACO

CRAACO tackles ways to strengthen care, patient connection

26-Apr-2021 By Jenni Spinner

The 6th annual Clinical Research as a Care Option conference, taking place April 26-27, brings together experts seeking solutions to elevate the industry.

Immunomics firm reels in $14m to advance drug discovery

20-Apr-2021 By Jenni Spinner

ImmunoScape plans to use the investor funds to grow its Asia presence, expand into the US, and to further develop its Deep Immunomics platform technology.

Syneos, Science 37 join to accelerate decentralized trials

20-Apr-2021 By Jenni Spinner

The two technology companies plan to work together to provide a unified platform that serves to streamline workflow, RWE generation and data harmonization.

FHIR can help tackle daunting digital challenges in research

19-Apr-2021 By Jenni Spinner

A leader from digital health solutions firm CitiusTech suggests use of fast healthcare interoperability resources is useful in the face of evolving tech.

Canine cancer research startup impacts treatment in humans

19-Apr-2021 By Jenni Spinner

One Health’s FidoCure is using genomics and AI technology to develop precision oncological treatments, and the work is benefiting human cancer research.

UK launches human challenge trial on COVID-19 reinfection

19-Apr-2021 By Rachel Arthur

A human challenge trial has been launched in the UK to investigate what happens when people who have already had COVID-19 are infected a second time.

Research institute taps into RWE to assess angioedema therapies

13-Apr-2021 By Jenni Spinner

The Institute for Clinical and Economic Review will use Aetion observational real-world evidence to evaluate potential drugs from Takeda and CSL Behring.

Decentralized trial model pushing research to ‘new standard’: AiCure

13-Apr-2021 By Jenni Spinner

A leader from the trial tech firm says COVID-19 has accelerated virtual studies, creating opportunities to improve patient engagement, costs and data.